{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:34:56Z","timestamp":1793968496774,"version":"4.8.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Jiao Tong University Medicine-Engineering Research Fund","award":["YG2021QN96"],"award-info":[{"award-number":["YG2021QN96"]}]},{"name":"Shanghai Jiao Tong University Medicine-Engineering Research Fund","award":["YG2022ZD019"],"award-info":[{"award-number":["YG2022ZD019"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001310"],"award-info":[{"award-number":["82001310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801236"],"award-info":[{"award-number":["81801236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071404"],"award-info":[{"award-number":["82071404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171373"],"award-info":[{"award-number":["82171373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20184Y0109"],"award-info":[{"award-number":["20184Y0109"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Science and Technology Project","award":["19411968100"],"award-info":[{"award-number":["19411968100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Microglia-mediated neuroinflammatory response following traumatic brain injury (TBI) is considered as a vital secondary injury factor, which drives trauma-induced neurodegeneration and is lack of efficient treatment. ACT001, a sesquiterpene lactone derivative, is reportedly involved in alleviation of inflammatory response. However, little is known regarding its function in regulating innate immune response of central nervous system (CNS) after TBI. This study aimed to investigate the role and underlying mechanism of ACT001 in TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Controlled cortical impact (CCI) models were used to establish model of TBI. Cresyl violet staining, evans blue extravasation, neurobehavioral function assessments, immunofluorescence and transmission electron microscopy were used to evaluate therapeutic effects of ACT001 in vivo. Microglial depletion was induced by administering mice with colony stimulating factor 1 receptor (CSF1R) inhibitor, PLX5622. Cell-cell interaction models were established as co-culture system to simulate TBI conditions in vitro. Cytotoxic effect of ACT001 on cell viability was assessed by cell counting kit-8 and activation of microglia cells were induced by Lipopolysaccharides (LPS). Pro-inflammatory cytokines expression was determined by Real-time PCR and nitric oxide production. Apoptotic cells were detected by TUNEL and flow cytometry assays. Tube formation was performed to evaluate cellular angiogenic ability. ELISA and western blot experiments were used to determine proteins expression. Pull-down assay was used to analyze proteins that bound ACT001.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ACT001 relieved the extent of blood-brain barrier integrity damage and alleviated motor function deficits after TBI via reducing trauma-induced activation of microglia cells. Delayed depletion of microglia with PLX5622 hindered therapeutic effect of ACT001. Furthermore, ACT001 alleviated LPS-induced activation in mouse and rat primary microglia cells. Besides, ACT001 was effective in suppressing LPS-induced pro-inflammatory cytokines production in BV2 cells, resulting in reduction of neuronal apoptosis in HT22 cells and improvement of tube formation in bEnd.3 cells. Mechanism by which ACT001 functioned was related to AKT\/NF\u03baB\/NLRP3 pathway. ACT001 restrained NF\u03baB nuclear translocation in microglia cells through inhibiting AKT phosphorylation, resulting in decrease of NLRP3 inflammasome activation, and finally down-regulated microglial neuroinflammatory response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study indicated that ACT001 played critical role in microglia-mediated neuroinflammatory response and might be a novel potential chemotherapeutic drug for TBI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-022-00862-y","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T08:02:59Z","timestamp":1650700979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NF\u03baB\/NLRP3 pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Lin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianxu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"key":"862_CR1","doi-asserted-by":"crossref","unstructured":"Menon DK, Schwab K, Wright DW, Maas AI, Health DaCAWGotIaIItCDEfRoTBIaP. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91:1637\u20131640.","DOI":"10.1016\/j.apmr.2010.05.017"},{"key":"862_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41582-018-0091-y","volume":"14","author":"T Mollayeva","year":"2018","unstructured":"Mollayeva T, Mollayeva S, Colantonio A. Traumatic brain injury: sex, gender and intersecting vulnerabilities. Nat Rev Neurol. 2018;14:711\u201322.","journal-title":"Nat Rev Neurol"},{"key":"862_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1089\/neu.2018.5942","volume":"36","author":"DX Yang","year":"2019","unstructured":"Yang DX, Jing Y, Liu YL, Xu ZM, Yuan F, Wang ML, et al. Inhibition of transient receptor potential vanilloid 1 attenuates blood-brain barrier disruption after traumatic brain injury in mice. J Neurotrauma. 2019;36:1279\u201390.","journal-title":"J Neurotrauma"},{"key":"862_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00001199-200307000-00003","volume":"18","author":"DH Smith","year":"2003","unstructured":"Smith DH, Meaney DF, Shull WH. Diffuse axonal injury in head trauma. J Head Trauma Rehabil. 2003;18:307\u201316.","journal-title":"J Head Trauma Rehabil"},{"key":"862_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/TA.0000000000001852","volume":"85","author":"SS Humble","year":"2018","unstructured":"Humble SS, Wilson LD, Wang L, Long DA, Smith MA, Siktberg JC, et al. Prognosis of diffuse axonal injury with traumatic brain injury. J Trauma Acute Care Surg. 2018;85:155\u20139.","journal-title":"J Trauma Acute Care Surg"},{"key":"862_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nurt.2009.10.023","volume":"7","author":"BA Stoica","year":"2010","unstructured":"Stoica BA, Faden AI. Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics. 2010;7:3\u201312.","journal-title":"Neurotherapeutics"},{"key":"862_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-017-0934-2","volume":"14","author":"X Xu","year":"2017","unstructured":"Xu X, Gao W, Cheng S, Yin D, Li F, Wu Y, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflammation. 2017;14:167.","journal-title":"J Neuroinflammation"},{"key":"862_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am. 2020;104:213\u201338.","journal-title":"Med Clin North Am"},{"key":"862_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.psc.2021.04.003","volume":"44","author":"SB Shively","year":"2021","unstructured":"Shively SB, Priemer DS, Stein MB, Perl DP. Pathophysiology of traumatic brain injury, chronic traumatic encephalopathy, and neuropsychiatric clinical expression. Psychiatr Clin North Am. 2021;44:443\u201358.","journal-title":"Psychiatr Clin North Am"},{"issue":"Pt 3","key":"862_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","volume":"275","author":"DJ Loane","year":"2016","unstructured":"Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275(Pt 3):316\u201327.","journal-title":"Exp Neurol"},{"key":"862_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","volume":"9","author":"CK Donat","year":"2017","unstructured":"Donat CK, Scott G, Gentleman SM, Sastre M. Microglial activation in traumatic brain injury. Front Aging Neurosci. 2017;9:208.","journal-title":"Front Aging Neurosci"},{"key":"862_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrneurol.2017.116","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW, McGeachy MJ, Bayir H, Clark RSB, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13:572.","journal-title":"Nat Rev Neurol"},{"key":"862_CR13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","volume":"364","author":"I Roberts","year":"2004","unstructured":"Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364:1321\u20138.","journal-title":"Lancet"},{"key":"862_CR14","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","volume":"371","author":"BE Skolnick","year":"2014","unstructured":"Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2467\u201376.","journal-title":"N Engl J Med"},{"key":"862_CR15","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387\u201394.","journal-title":"Nat Neurosci"},{"key":"862_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00005-016-0405-y","volume":"64","author":"A Panday","year":"2016","unstructured":"Panday A, Inda ME, Bagam P, Sahoo MK, Osorio D, Batra S. Transcription factor NF-kappaB: an update on intervention strategies. Arch Immunol Ther Exp (Warsz). 2016;64:463\u201383.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"862_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/1871527319666200918145903","volume":"20","author":"M Nathalie","year":"2021","unstructured":"Nathalie M, Polineni SP, Chin CN, Fawcett D, Clervius H, Maria QSL, et al. Targeting microglial polarization to improve TBI outcomes. CNS Neurol Disord Drug Targets. 2021;20:216\u201327.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"862_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2174\/156652401509151105130628","volume":"15","author":"GC Brown","year":"2015","unstructured":"Brown GC, Vilalta A, Fricker M. Phagoptosis\u2014cell death by phagocytosis\u2014plays central roles in physiology, host defense and pathology. Curr Mol Med. 2015;15:842\u201351.","journal-title":"Curr Mol Med"},{"key":"862_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70:374\u201383.","journal-title":"Ann Neurol"},{"key":"862_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","volume":"6","author":"D Shlosberg","year":"2010","unstructured":"Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol. 2010;6:393\u2013403.","journal-title":"Nat Rev Neurol"},{"key":"862_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-016-0382-8","volume":"4","author":"JD Cherry","year":"2016","unstructured":"Cherry JD, Tripodis Y, Alvarez VE, Huber B, Kiernan PT, Daneshvar DH, et al. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun. 2016;4:112.","journal-title":"Acta Neuropathol Commun"},{"key":"862_CR22","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.2174\/138161212803530763","volume":"18","author":"C Gasparini","year":"2012","unstructured":"Gasparini C, Feldmann M. NF-kappaB as a target for modulating inflammatory responses. Curr Pharm Des. 2012;18:5735\u201345.","journal-title":"Curr Pharm Des"},{"key":"862_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1073858412444007","volume":"19","author":"S Mincheva-Tasheva","year":"2013","unstructured":"Mincheva-Tasheva S, Soler RM. NF-kappaB signaling pathways: role in nervous system physiology and pathology. Neuroscientist. 2013;19:175\u201394.","journal-title":"Neuroscientist"},{"key":"862_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","volume":"10","author":"EC Dresselhaus","year":"2019","unstructured":"Dresselhaus EC, Meffert MK. Cellular specificity of NF-kappaB function in the nervous system. Front Immunol. 2019;10:1043.","journal-title":"Front Immunol"},{"key":"862_CR25","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.1021\/jm301064b","volume":"55","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem. 2012;55:8757\u201369.","journal-title":"J Med Chem"},{"key":"862_CR26","doi-asserted-by":"publisher","first-page":"e0116202","DOI":"10.1371\/journal.pone.0116202","volume":"10","author":"Y An","year":"2015","unstructured":"An Y, Guo W, Li L, Xu C, Yang D, Wang S, et al. Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivo. PLoS ONE. 2015;10:e0116202.","journal-title":"PLoS ONE"},{"key":"862_CR27","doi-asserted-by":"publisher","first-page":"111471","DOI":"10.1016\/j.biopha.2021.111471","volume":"138","author":"J Jaffar","year":"2021","unstructured":"Jaffar J, Glaspole I, Symons K, Westall G. Inhibition of NF-kappaB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis. Biomed Pharmacother. 2021;138:111471.","journal-title":"Biomed Pharmacother"},{"key":"862_CR28","doi-asserted-by":"publisher","first-page":"112337","DOI":"10.1016\/j.bbr.2019.112337","volume":"379","author":"Q Liu","year":"2020","unstructured":"Liu Q, Zhang S, Zhu D, Tang X, Che Y, Feng X. The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson\u2019s disease in mice. Behav Brain Res. 2020;379:112337.","journal-title":"Behav Brain Res"},{"key":"862_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/labinvest.2014.89","volume":"94","author":"E Viennois","year":"2014","unstructured":"Viennois E, Xiao B, Ayyadurai S, Wang L, Wang PG, Zhang Q, et al. Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer. Lab Investig. 2014;94:950\u201365.","journal-title":"Lab Investig"},{"key":"862_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.drudis.2010.06.002","volume":"15","author":"A Ghantous","year":"2010","unstructured":"Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today. 2010;15:668\u201378.","journal-title":"Drug Discov Today"},{"key":"862_CR31","doi-asserted-by":"publisher","first-page":"247685","DOI":"10.1155\/2015\/247685","volume":"2015","author":"B Ivanescu","year":"2015","unstructured":"Ivanescu B, Miron A, Corciova A. Sesquiterpene lactones from artemisia genus: biological activities and methods of analysis. J Anal Methods Chem. 2015;2015:247685.","journal-title":"J Anal Methods Chem"},{"key":"862_CR32","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1074\/jbc.273.3.1288","volume":"273","author":"SP Hehner","year":"1998","unstructured":"Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, et al. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J Biol Chem. 1998;273:1288\u201397.","journal-title":"J Biol Chem"},{"key":"862_CR33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1165\/rcmb.2006-0323OC","volume":"36","author":"A Saadane","year":"2007","unstructured":"Saadane A, Masters S, DiDonato J, Li J, Berger M. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol. 2007;36:728\u201336.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"862_CR34","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.1208\/pt0804105","volume":"8","author":"P Jin","year":"2007","unstructured":"Jin P, Madieh S, Augsburger LL. The solution and solid state stability and excipient compatibility of parthenolide in feverfew. AAPS PharmSciTech. 2007;8:E105.","journal-title":"AAPS PharmSciTech"},{"key":"862_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jchromb.2018.11.004","volume":"1104","author":"XN Xi","year":"2019","unstructured":"Xi XN, Liu N, Wang QQ, Wu HT, He HB, Wang LL, et al. Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1104:29\u201339.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"862_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00109-019-01839-0","volume":"98","author":"Q Li","year":"2020","unstructured":"Li Q, Sun Y, Liu B, Li J, Hao X, Ge W, et al. ACT001 modulates the NF-kappaB\/MnSOD\/ROS axis by targeting IKKbeta to inhibit glioblastoma cell growth. J Mol Med (Berl). 2020;98:263\u201377.","journal-title":"J Mol Med (Berl)"},{"key":"862_CR37","doi-asserted-by":"publisher","first-page":"e14048","DOI":"10.1200\/JCO.2018.36.15_suppl.e14048","volume":"36","author":"JD Lickliter","year":"2018","unstructured":"Lickliter JD, Jennens R, Lemech CR, Su SYC, Chen Y. Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors. J Clin Oncol. 2018;36:e14048\u2013e14048.","journal-title":"J Clin Oncol"},{"key":"862_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","volume":"10","author":"X Xi","year":"2019","unstructured":"Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y, Lu Y. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma. Cell Death Dis. 2019;10:757.","journal-title":"Cell Death Dis"},{"key":"862_CR39","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10:5943\u201356.","journal-title":"Theranostics"},{"key":"862_CR40","doi-asserted-by":"crossref","unstructured":"Tamashiro TT, Dalgard CL, Byrnes KR. Primary microglia isolation from mixed glial cell cultures of neonatal rat brain tissue. J Vis Exp. 2012:e3814.","DOI":"10.3791\/3814"},{"key":"862_CR41","doi-asserted-by":"crossref","unstructured":"Du S, Xiong S, Du X, Yuan TF, Peng B, Rao Y. Primary Microglia Isolation from Postnatal Mouse Brains. J Vis Exp. 2021.","DOI":"10.3791\/62237"},{"key":"862_CR42","doi-asserted-by":"crossref","unstructured":"Schwulst SJ, Islam M. Murine model of controlled cortical impact for the induction of traumatic brain injury. J Vis Exp. 2019.","DOI":"10.3791\/60027"},{"key":"862_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1471-4159.2008.05633.x","volume":"107","author":"RJ Horvath","year":"2008","unstructured":"Horvath RJ, Nutile-McMenemy N, Alkaitis MS, Deleo JA. Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J Neurochem. 2008;107:557\u201369.","journal-title":"J Neurochem"},{"key":"862_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-016-0644-1","volume":"13","author":"A Das","year":"2016","unstructured":"Das A, Kim SH, Arifuzzaman S, Yoon T, Chai JC, Lee YS, et al. Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microglia. J Neuroinflammation. 2016;13:182.","journal-title":"J Neuroinflammation"},{"key":"862_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.intimp.2014.08.003","volume":"23","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Zhang L, Zhou C, Wu H. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo. Int Immunopharmacol. 2014;23:14\u201326.","journal-title":"Int Immunopharmacol"},{"key":"862_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lfs.2016.01.041","volume":"147","author":"EC Rios","year":"2016","unstructured":"Rios EC, de Lima TM, Moretti AI, Soriano FG. The role of nitric oxide in the epigenetic regulation of THP-1 induced by lipopolysaccharide. Life Sci. 2016;147:110\u20136.","journal-title":"Life Sci"},{"key":"862_CR47","doi-asserted-by":"publisher","first-page":"e13375","DOI":"10.1111\/acel.13375","volume":"20","author":"C Gu","year":"2021","unstructured":"Gu C, Wang F, Zhang YT, Wei SZ, Liu JY, Sun HY, et al. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20:e13375.","journal-title":"Aging Cell"},{"key":"862_CR48","doi-asserted-by":"publisher","first-page":"102010","DOI":"10.1016\/j.redox.2021.102010","volume":"44","author":"X Han","year":"2021","unstructured":"Han X, Xu T, Fang Q, Zhang H, Yue L, Hu G, Sun L. Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol. 2021;44:102010.","journal-title":"Redox Biol"},{"key":"862_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41467-017-00037-1","volume":"8","author":"YM Morizawa","year":"2017","unstructured":"Morizawa YM, Hirayama Y, Ohno N, Shibata S, Shigetomi E, Sui Y, et al. Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat Commun. 2017;8:28.","journal-title":"Nat Commun"},{"key":"862_CR50","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1038\/s41467-021-27248-x","volume":"12","author":"X Shi","year":"2021","unstructured":"Shi X, Luo L, Wang J, Shen H, Li Y, Mamtilahun M, et al. Stroke subtype-dependent synapse elimination by reactive gliosis in mice. Nat Commun. 2021;12:6943.","journal-title":"Nat Commun"},{"key":"862_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bpa.12256","volume":"26","author":"ZB Wu","year":"2016","unstructured":"Wu ZB, Cai L, Lin SJ, Leng ZG, Guo YH, Yang WL, et al. Heat shock protein 47 promotes glioma angiogenesis. Brain Pathol. 2016;26:31\u201342.","journal-title":"Brain Pathol"},{"key":"862_CR52","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1021\/acs.jmedchem.8b00241","volume":"61","author":"J Li","year":"2018","unstructured":"Li J, Li S, Guo J, Li Q, Long J, Ma C, et al. Natural product micheliolide (MCL) irreversibly activates pyruvate kinase m2 and suppresses leukemia. J Med Chem. 2018;61:4155\u201364.","journal-title":"J Med Chem"},{"key":"862_CR53","doi-asserted-by":"crossref","unstructured":"Liu Q, Guo X, Huang Z, He Q, Zhu D, Zhang S, et al. Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 in fl ammasome in MPTP-induced Parkinson disease in mice. Behav Brain Res. 2020;383:112539.","DOI":"10.1016\/j.bbr.2020.112539"},{"key":"862_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"IC Hoogland","year":"2015","unstructured":"Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015;12:114.","journal-title":"J Neuroinflammation"},{"key":"862_CR55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380\u201397.","journal-title":"Neuron"},{"key":"862_CR56","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41467-019-08446-0","volume":"10","author":"V Bellver-Landete","year":"2019","unstructured":"Bellver-Landete V, Bretheau F, Mailhot B, Vallieres N, Lessard M, Janelle ME, et al. Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury. Nat Commun. 2019;10:518.","journal-title":"Nat Commun"},{"key":"862_CR57","doi-asserted-by":"crossref","unstructured":"Willis EF, MacDonald KPA, Nguyen QH, Garrido AL, Gillespie ER, Harley SBR, et al. Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner. Cell. 2020;180:833\u2013846 e816.","DOI":"10.1016\/j.cell.2020.02.013"},{"key":"862_CR58","doi-asserted-by":"publisher","first-page":"15629","DOI":"10.1074\/jbc.M806139200","volume":"284","author":"DJ Loane","year":"2009","unstructured":"Loane DJ, Stoica BA, Pajoohesh-Ganji A, Byrnes KR, Faden AI. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem. 2009;284:15629\u201339.","journal-title":"J Biol Chem"},{"key":"862_CR59","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/neu.2012.2589","volume":"30","author":"DJ Loane","year":"2013","unstructured":"Loane DJ, Stoica BA, Byrnes KR, Jeong W, Faden AI. Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury. J Neurotrauma. 2013;30:403\u201312.","journal-title":"J Neurotrauma"},{"key":"862_CR60","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1124\/jpet.118.253955","volume":"368","author":"A Kumar","year":"2019","unstructured":"Kumar A, Henry RJ, Stoica BA, Loane DJ, Abulwerdi G, Bhat SA, Faden AI. Neutral sphingomyelinase inhibition alleviates lps-induced microglia activation and neuroinflammation after experimental traumatic brain injury. J Pharmacol Exp Ther. 2019;368:338\u201352.","journal-title":"J Pharmacol Exp Ther"},{"key":"862_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-2094-9-115","volume":"9","author":"B Stansley","year":"2012","unstructured":"Stansley B, Post J, Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer\u2019s disease. J Neuroinflammation. 2012;9:115.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"862_CR62","doi-asserted-by":"publisher","first-page":"H434","DOI":"10.1152\/ajpheart.2001.280.1.H434","volume":"280","author":"Wen Wang","year":"2001","unstructured":"Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol. 2001;280:H434-440.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"1","key":"862_CR63","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12035-014-8848-9","volume":"52","author":"Li-Feng Wang","year":"2015","unstructured":"Wang LF, Li X, Gao YB, Wang SM, Zhao L, Dong J, et al. Activation of VEGF\/Flk-1-ERK Pathway Induced Blood-Brain Barrier Injury After Microwave Exposure. Mol Neurobiol. 2015;52:478-491.","journal-title":"Molecular Neurobiology"},{"key":"862_CR64","doi-asserted-by":"crossref","unstructured":"Inada M, Xu H, Takeuchi M, Ito M, Chen M. Microglia increase tight-junction permeability in coordination with Muller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier. Exp Eye Res. 2021;205:108490.","DOI":"10.1016\/j.exer.2021.108490"},{"key":"862_CR65","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","volume":"95","author":"YN Jassam","year":"2017","unstructured":"Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron. 2017;95:1246\u201365.","journal-title":"Neuron"},{"key":"862_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12974-020-01778-5","volume":"17","author":"WT O'Brien","year":"2020","unstructured":"O\u2019Brien WT, Pham L, Symons GF, Monif M, Shultz SR, McDonald SJ. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflamm. 2020;17:104.","journal-title":"J Neuroinflamm"},{"key":"862_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/1673-5374.286951","volume":"16","author":"S Ismael","year":"2021","unstructured":"Ismael S, Ahmed HA, Adris T, Parveen K, Thakor P, Ishrat T. The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury. Neural Regen Res. 2021;16:49\u201357.","journal-title":"Neural Regen Res"},{"key":"862_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/43466","volume":"401","author":"ON Ozes","year":"1999","unstructured":"Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 1999;401:82\u20135.","journal-title":"Nature"},{"key":"862_CR69","doi-asserted-by":"publisher","first-page":"e0186592","DOI":"10.1371\/journal.pone.0186592","volume":"12","author":"Z Sun","year":"2017","unstructured":"Sun Z, Li G, Tong T, Chen J. Micheliolide suppresses LPS-induced neuroinflammatory responses. PLoS ONE. 2017;12:e0186592.","journal-title":"PLoS ONE"},{"key":"862_CR70","first-page":"2432904","volume":"2017","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Jiang X, He W, Wei K, Sun J, Qin X, et al. MCL plays an anti-inflammatory role in mycobacterium tuberculosis-induced immune response by inhibiting NF-kappaB and NLRP3 inflammasome activation. Mediators Inflamm. 2017;2017:2432904.","journal-title":"Mediators Inflamm"},{"key":"862_CR71","doi-asserted-by":"publisher","first-page":"104506","DOI":"10.1016\/j.phrs.2019.104506","volume":"150","author":"W Liu","year":"2019","unstructured":"Liu W, Chen X, Wang Y, Chen Y, Chen S, Gong W, et al. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db\/db mice. Pharmacol Res. 2019;150:104506.","journal-title":"Pharmacol Res"},{"key":"862_CR72","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176:287\u201392.","journal-title":"J Exp Med"},{"key":"862_CR73","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841\u20135.","journal-title":"Science"},{"key":"862_CR74","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature13989","volume":"518","author":"E Gomez Perdiguero","year":"2015","unstructured":"Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518:547\u201351.","journal-title":"Nature"},{"key":"862_CR75","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987\u201391.","journal-title":"Nat Neurosci"},{"key":"862_CR76","doi-asserted-by":"publisher","first-page":"e0148001","DOI":"10.1371\/journal.pone.0148001","volume":"11","author":"JM Morganti","year":"2016","unstructured":"Morganti JM, Riparip LK, Rosi S. Call off the Dog(ma): M1\/M2 polarization is concurrent following traumatic brain injury. PLoS ONE. 2016;11:e0148001.","journal-title":"PLoS ONE"},{"key":"862_CR77","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","volume":"43","author":"X Hu","year":"2012","unstructured":"Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al. Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43:3063\u201370.","journal-title":"Stroke"},{"key":"862_CR78","doi-asserted-by":"publisher","first-page":"e41892","DOI":"10.1371\/journal.pone.0041892","volume":"7","author":"X Jin","year":"2012","unstructured":"Jin X, Ishii H, Bai Z, Itokazu T, Yamashita T. Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL\/6 mice. PLoS ONE. 2012;7:e41892.","journal-title":"PLoS ONE"},{"key":"862_CR79","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/aps.2016.162","volume":"38","author":"SC Zhao","year":"2017","unstructured":"Zhao SC, Ma LS, Chu ZH, Xu H, Wu WQ, Liu F. Regulation of microglial activation in stroke. Acta Pharmacol Sin. 2017;38:445\u201358.","journal-title":"Acta Pharmacol Sin"},{"key":"862_CR80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.12458","volume":"1319","author":"FS Sutterwala","year":"2014","unstructured":"Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 2014;1319:82\u201395.","journal-title":"Ann N Y Acad Sci"},{"key":"862_CR81","doi-asserted-by":"crossref","unstructured":"Ji W, Liang K, An R, Wang X. Baicalin protects against ethanol-induced chronic gastritis in rats by inhibiting Akt\/NF-kappaB pathway. Life Sci. 2019;239:117064.","DOI":"10.1016\/j.lfs.2019.117064"},{"key":"862_CR82","doi-asserted-by":"crossref","unstructured":"Bang E, Kim DH, Chung HY. Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-kappaB and FoxO6 modulation during skin photoaging. Redox Biol. 2021;44:102022.","DOI":"10.1016\/j.redox.2021.102022"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-022-00862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-022-00862-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-022-00862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:05:15Z","timestamp":1652839515000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-022-00862-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1186\/s12964-022-00862-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,23]]},"assertion":[{"value":"6 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subjects or samples were not used in this study. All animal operational procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University, Shanghai, China and reported according to the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}